C07C 311/19
To an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl
Official title: to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
C07C311/19 (To an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl) appears on 387 US grants and 303 published applications in this corpus.
Search patents in C07C- Granted patents
- 387
- Published applications
- 303
- Assignees
- 230
- Inventors
- 1,322
- Latest grant
- 10 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 12 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 3 | 0 |
| 1991 | 4 | 0 |
| 1992 | 7 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 12 | 0 |
| 1996 | 13 | 0 |
| 1997 | 19 | 0 |
| 1998 | 14 | 0 |
| 1999 | 18 | 0 |
| 2000 | 17 | 0 |
| 2001 | 26 | 5 |
| 2002 | 22 | 15 |
| 2003 | 25 | 29 |
| 2004 | 16 | 30 |
| 2005 | 13 | 24 |
| 2006 | 12 | 11 |
| 2007 | 13 | 15 |
| 2008 | 14 | 14 |
| 2009 | 11 | 20 |
| 2010 | 8 | 7 |
| 2011 | 13 | 14 |
| 2012 | 9 | 12 |
| 2013 | 7 | 8 |
| 2014 | 8 | 10 |
| 2015 | 4 | 12 |
| 2016 | 11 | 10 |
| 2017 | 9 | 10 |
| 2018 | 9 | 6 |
| 2019 | 8 | 11 |
| 2020 | 7 | 6 |
| 2021 | 5 | 9 |
| 2022 | 4 | 8 |
| 2023 | 1 | 7 |
| 2024 | 3 | 2 |
| 2025 | 1 | 6 |
| 2026 | 3 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Multifunctional linker compounds10 Mar 2026US 12,570,600 B220Bloc, Inc.
- Heterodimers of glutamic acid27 Jan 2026US 12,534,429 B2Molecular Insight Pharmaceuticals, Inc.
- Process for the preparation of high pure Eribulin and its Mesylate salt13 Jan 2026US 12,522,611 B2Natco Pharma Limited
- Modulators of sestrin-GATOR2 interaction and uses thereof5 Aug 2025US 12,378,263 B2Navitor Pharmaceuticals, Inc.
- Carbon monoxide prodrugs for the treatment of medical disorders27 Aug 2024US 12,071,415 B2Georgia State University Research Foundation, Inc.
- Small molecule direct inhibitors of keap1-nrf2 protein-protein interaction11 Jun 2026US 2026/0158027 A1Rutgers, The State University of New Jersey
- Modulators of sestrin-gator2 interaction and uses thereof26 Feb 2026US 2026/0055122 A1Navitor Pharmaceuticals, Inc.
- Compounds As NLRP3 Inflammasome Inhibitors And Their Use As Medicaments18 Sep 2025US 2025/0289810 A1Mam-Age S.R.L.
- Multifunctional linker compounds31 Jul 2025US 2025/0243148 A120Bloc, Inc.
- 1,6-diyne compound, its preparation method, and products obtained using 1,6-diyne compound as raw material and their applications12 Jun 2025US 2025/0189532 A1Fujian Institute of Research On the Structure of Matter, Chinese Academy of Sciences
Most cited
By later US patents
- Compositions for oral delivery of active agents159US 5,650,386 AEmisphere Technologies, Inc. · 1997
- Compounds and compositions for delivering active agents125US 5,866,536 AEmisphere Technologies, Inc. · 1999
- Arylsulfonamido-substituted hydroxamic acids110US 5,455,258 ACiba-Geigy Corporation · 1995
- Cycloalkyl-substituted glutaramide antihypertensive agents88US 4,975,444 APfizer Inc. · 1990
- Arylsulfonamido-substituted hydroxamic acids85US 5,552,419 ACiba-Geigy Corporation · 1996